一个有效性实施试验协议,以评估在使用eHealth工具与标准护理相比,在使用eHealth工具的美国cisgender女性中启动PrEP
Lillee H Izadi1, Okeoma Mmeje2, Emmanuel F Drabo3
1Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Frontiers in reproductive health
|June 26, 2023
概括
这项研究测试了在巴尔的摩市的 cisgender 女性中增加暴露前预防 (PrEP) 的干预措施. 电子健康记录的整合和提供者警报显示了改善艾滋病毒预防策略的前景.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 妇女健康 妇女健康
背景情况:
- 尽管有国家预防工作,但在美国,女性占艾滋病毒新诊断的很大比例.
- 暴露前预防 (PrEP) 是一种有效的艾滋病毒预防方法,但其在 cisgender 妇女中的吸收仍然不够理想.
- 2019年,在美国,只有10%的符合条件的 cisgender 女性获得了 PrEP 处方.
研究的目的:
- 评估旨在增加cisgender女性PrEP启动的干预措施的有效性.
- 评估这些干预措施在产科和妇科 (OB / GYN) 诊所中的实施策略.
- 为了比较标准护理,患者层面和多层面干预措施对PrEP启动率的影响.
主要方法:
- 在马里兰州巴尔的摩的七家妇产科医生诊所进行了一项混合II型临床试验.
- 42名妇产科医生被随机分为三个部门:标准护理,患者级干预或多级干预.
- 一个电子健康记录 (EHR) 问卷评估了患者的艾滋病毒风险,告知了干预指派和PrEP资格.
主要成果:
- 这项研究旨在分析使用通用线性混合效应模型在三个手臂中PrEP启动的差异.
- 结果将根据人口变化进行调整,并按患者和提供者种族和种族分层.
- 将对每个干预措施进行全面的经济分析.
结论:
- 该研究假设,对性行为的电子数据收集,对艾滋病毒风险的明确沟通以及电子病历警报将增强PrEP启动和艾滋病毒检测.
- 研究结果将为改善在常规妇产科医生护理中改善 cisgender 女人的艾滋病毒预防策略提供信息.
- 该试验已在临床试验.gov (NCT05412433) 上注册.
关键词:
欧洲健康日志的干预预防艾滋病毒 预防艾滋病毒顺性别女性 (cisgender women) 是一个女性.数字健康数字健康结束艾滋病毒流行病 (EHE)暴露前预防 (PrEP) 是指暴露前的预防.更多相关视频
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.3K
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
11.9K
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Study Designs in Epidemiology
284
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
284
Hazard Ratio
166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
166
